| Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients S Calarota, G Bratt, S Nordlund, J Hinkula, AC Leandersson, E Sandström, ... The Lancet 351 (9112), 1320-1325, 1998 | 507 | 1998 |
| Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells C Devito, K Broliden, R Kaul, L Svensson, K Johansen, P Kiama, J Kimani, ... The Journal of Immunology 165 (9), 5170-5176, 2000 | 297 | 2000 |
| Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate C Devito, J Hinkula, R Kaul, L Lopalco, JJ Bwayo, F Plummer, M Clerici, ... Aids 14 (13), 1917-1920, 2000 | 246 | 2000 |
| Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects C Devito, J Hinkula, R Kaul, J Kimani, P Kiama, L Lopalco, C Barass, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 30 (4), 413-420, 2002 | 178 | 2002 |
| Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals A Cosma, R Nagaraj, S Bühler, J Hinkula, DH Busch, G Sutter, FD Goebel, ... Vaccine 22 (1), 21-29, 2003 | 173 | 2003 |
| Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers K Broliden, J Hinkula, C Devito, P Kiama, J Kimani, D Trabbatoni, ... Immunology letters 79 (1-2), 29-36, 2001 | 149 | 2001 |
| Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment SA Calarota, AC Leandersson, G Bratt, J Hinkula, DM Klinman, ... The Journal of Immunology 163 (4), 2330-2338, 1999 | 141 | 1999 |
| Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin SE Applequist, E Rollman, MD Wareing, M Lidén, B Rozell, J Hinkula, ... The Journal of Immunology 175 (6), 3882-3891, 2005 | 133 | 2005 |
| Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41 M Clerici, C Barassi, C Devito, C Pastori, S Piconi, D Trabattoni, R Longhi, ... Aids 16 (13), 1731-1741, 2002 | 122 | 2002 |
| Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp 120 L Åkerblom, J Hinkula, PA Broliden, B Mäkitalo, T Fridberger, J Rosen, ... Aids 4 (10), 953-960, 1990 | 106 | 1990 |
| A nonsense mutation (428G→ A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection E Kindberg, B Hejdeman, G Bratt, B Wahren, B Lindblom, J Hinkula, ... Aids 20 (5), 685-689, 2006 | 100 | 2006 |
| Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery A Bråve, K Ljungberg, A Boberg, E Rollman, M Isaguliants, B Lundgren, ... Molecular Therapy 12 (6), 1197-1205, 2005 | 100 | 2005 |
| Humoral and cell‐mediated immune responses in humans to the NSP4 enterotoxin of rotavirus K Johansen, J Hinkula, F Espinoza, M Levi, C Zeng, U Rudén, T Vesikari, ... Journal of medical virology 59 (3), 369-377, 1999 | 99 | 1999 |
| Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes J Hinkula, C Svanholm, S Schwartz, P Lundholm, M Brytting, G Engström, ... Journal of virology 71 (7), 5528-5539, 1997 | 96 | 1997 |
| Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA P Lundholm, Y Asakura, J Hinkula, E Lucht, B Wahren Vaccine 17 (15-16), 2036-2042, 1999 | 95 | 1999 |
| Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA AK Zuber, A Bråve, G Engström, B Zuber, K Ljungberg, M Fredriksson, ... Vaccine 22 (13-14), 1791-1798, 2004 | 92 | 2004 |
| Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics VA Sundqvist, J Albert, E Ohlsson, J Hinkula, EM Fenyö, B Wahren Journal of medical virology 29 (3), 170-175, 1989 | 90 | 1989 |
| Immunization with DNA plasmids coding for Crimean-Congo hemorrhagic fever virus capsid and envelope proteins and/or virus-like particles induces protection and survival in … J Hinkula, S Devignot, S Åkerström, H Karlberg, E Wattrang, S Bereczky, ... Journal of virology 91 (10), 10.1128/jvi. 02076-16, 2017 | 89 | 2017 |
| DNA–VLP prime–boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity L Buonaguro, C Devito, ML Tornesello, U Schröder, B Wahren, J Hinkula, ... Vaccine 25 (32), 5968-5977, 2007 | 86 | 2007 |
| NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients SE Johansson, E Rollman, AW Chung, RJ Center, B Hejdeman, I Stratov, ... Viral immunology 24 (5), 359-368, 2011 | 85 | 2011 |
